+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Lithium carbonate treatment of mania. Cerebrospinal fluid and urinary monoamine metabolites and treatment outcome



Lithium carbonate treatment of mania. Cerebrospinal fluid and urinary monoamine metabolites and treatment outcome



Archives of General Psychiatry 44(4): 345-354



Treatment of manic patients with lithium carbonate was associated with significant decreases in cerebrospinal fluid (CSF) 3-methoxy-4-hydroxyphenylglycol (MHPG) and urinary norepinephrine excretion. These measures, before treatment, were higher in manic patients than in either depressed or normal subjects and correlated significantly with severity of mania. Levels in CSF of homovanillic acid and 5-hydroxyindoleacetic acid did not correlate with severity or with change during lithium carbonate treatment. Responders (about 70% of the patients) did not differ from nonresponders in pretreatment mania ratings or neurotransmitter measures. The CSF MHPG and urinary norepinephrine excretion were reduced during lithium carbonate treatment in both responders and nonresponders. Unlike the case before treatment, urinary MHPG excretion was higher during treatment in nonresponders than in responders and correlated with several indexes of symptom severity. These results support a relationship between mania and increased noradrenergic function. Treatment outcome, however, was not related exclusively to the reduction of noradrenergic indexes by lithium carbonate since reductions were similar in both responders and nonresponders. Reduced noradrenergic activity may therefore be necessary but not sufficient for successful outcome during lithium carbonate treatment.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 005818837

Download citation: RISBibTeXText

PMID: 2436590


Related references

Lithium distribution in mania plasma and red blood cell lithium clinical state and monoamine metabolites during lithium treatment. Psychiatry Research 20(1): 1-12, 1987

The effect of lithium treatment on manic symptoms and levels of monoamine metabolites in cerebrospinal fluid of manic depressive patients. Psychopharmacologia 44(1): 99-103, 1975

Acid monoamine metabolites of cerebrospinal fluid in mental depression and mania. Journal of Neurochemistry 13(12): 1545-1548, 1966

Monoamine metabolites in cerebrospinal fluid during treatment of hypertension with prazosin. European Journal of Clinical Pharmacology 18(5): 399-401, 1980

Monoamine metabolites in cerebrospinal fluid during treatment with clonidine or alprenolol. European Journal of Clinical Pharmacology 11(2): 125-128, 1977

Lithium: clinical effects and cerebrospinal fluid acid monoamine metabolites. Communications in Psychopharmacology 1(2): 135-145, 1977

Changes in cerebrospinal fluid monoamine metabolites during long-term antidepressant treatment. European Neuropsychopharmacology 10(5): 341-349, September, 2000

Monoamine metabolites in cerebrospinal fluid of depressed patients during treatment with mianserin or amitriptyline. Journal of Affective Disorders 4(3): 219-226, 1982

Monoamine metabolites in cerebrospinal fluid and serotonin uptake inhibition during treatment with chlorimipramine. Clinical Pharmacology and Therapeutics 21(2): 201-207, 1977

Comparison of efficacy of lithium carbonate and chlorpromazine in mania. Report of collaborative study group on treatment of mania in Japan. Archives of General Psychiatry 32(10): 1310-1318, 1975

Biochemical effects of antidepressant treatment--studies of monoamine metabolites in cerebrospinal fluid and platelet [3H]imipramine binding. Ciba Foundation Symposium 123: 57-83, 1986

Tricyclic antidepressant washout effects on cerebrospinal fluid and urinary monoamine and metabolites. Archives of General Psychiatry 43(10): 1012-1013, 1986

Fluoxetine treatment of depression. Clinical effects, drug concentrations and monoamine metabolites and N-terminally extended substance P in cerebrospinal fluid. Acta Psychiatrica Scandinavica 79(6): 586-596, 1989

Treatment of mania with lithium carbonate. Nederlands Tijdschrift Voor Geneeskunde 105: 323-325, 1961